Aptagen, LLC
sk6Ea (ID# 7998)
DNA
SK-BR-3 cells (HER2 positive)
Cells
34.79-63.85 nM (reported value)
PBS (pH 7.4), 5 mM MgCl2, 4.5 g/L glucose, 0.1 mg/mL yeast tRNA, 1 mg/mL BSA
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5’-dTpdCpdAp dCpdGpdCp dCpdCpdGp dApdTpdAp dApdGpdGp dGpdCpdGp dApdTpdGp dCpdCpdGp dApdTpdCp dCpdCpdTp dGpdTpdGp dGpdCpdCp dGpdTpdAp dGpdGpdGp dCpdApdGp dTpdCpdCp dCpdCpdTp dApdGp-3’
53
16296.5
493200
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Liu, M.; Wang, Z.; Tan, T.; Chen, Z.; Mou, X.; Yu, X.; Deng, Y.; Lu, G.; He, N. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer. Theranostics. 2018, 8, 5772-5783.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.